SCIE期刊Journal for ImmunoTherapy of Cancer 2024/2025影响因子:10.388 (J IMMUNOTHER CANCER) (NULL). (ONCOLOGY)(肿瘤学)Science Cit

显示全部楼层 · 发表于 2025-3-25 11:17:19

Submitted on: 30 July 2018. Revised on: 24 November 2018. Accepted on: 09 January 2019. ___________________Journal for ImmunoTherapy of Cancer

显示全部楼层 · 发表于 2025-3-25 14:41:01

Submitted on: 04 September 2018. Revised on: 20 December 2018. Accepted on: 15 January 2019. ___________________Journal for ImmunoTherapy of Cancer

显示全部楼层 · 发表于 2025-3-25 16:04:41

显示全部楼层 · 发表于 2025-3-25 23:42:24

Submitted on: 09 July 2000. Revised on: 19 August 2000. Accepted on: 05 September 2000. ___________________Journal for ImmunoTherapy of Cancer

显示全部楼层 · 发表于 2025-3-26 03:29:50

显示全部楼层 · 发表于 2025-3-26 07:05:48

显示全部楼层 · 发表于 2025-3-26 10:06:36

Submitted on: 25 August 2010. Revised on: 26 September 2010. Accepted on: 15 November 2010. ___________________Journal for ImmunoTherapy of Cancer

显示全部楼层 · 发表于 2025-3-26 15:18:26

Submitted on: 17 March 2006. Revised on: 22 April 2006. Accepted on: 17 June 2006. ___________________Journal for ImmunoTherapy of Cancer

显示全部楼层 · 发表于 2025-3-26 20:52:34

Submitted on: 16 October 1999. Revised on: 29 November 1999. Accepted on: 25 December 1999. ___________________Journal for ImmunoTherapy of Cancer

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-20 12:58
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved